000 | 01182 a2200301 4500 | ||
---|---|---|---|
005 | 20250517141451.0 | ||
264 | 0 | _c20180423 | |
008 | 201804s 0 0 eng d | ||
022 | _a1752-2978 | ||
024 | 7 |
_a10.1097/MED.0000000000000330 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoman-Gonzalez, Alejandro | |
245 | 0 | 0 |
_aMalignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials. _h[electronic resource] |
260 |
_bCurrent opinion in endocrinology, diabetes, and obesity _cJun 2017 |
||
300 |
_a174-183 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aParaganglioma _xdiagnosis |
650 | 0 | 4 |
_aPheochromocytoma _xdiagnosis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRadiopharmaceuticals _xtherapeutic use |
700 | 1 | _aJimenez, Camilo | |
773 | 0 |
_tCurrent opinion in endocrinology, diabetes, and obesity _gvol. 24 _gno. 3 _gp. 174-183 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/MED.0000000000000330 _zAvailable from publisher's website |
999 |
_c26911320 _d26911320 |